Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Migration, Crosslink

📖

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

active

wiki page Created: 2026-04-02T07:19:00 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-neurofeedback-bci-cbs-

📖 Wiki Page

therapeutic1149 wordssynced 2026-04-02

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Introduction

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP</th>
</tr>
<tr>
<td class="label">Device</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Neuroflow</td>
<td>sLORETA</td>
</tr>
<tr>
<td class="label">Myndlift</td>
<td>EEG</td>
</tr>
<tr>
<td class="label">Brainbit</td>
<td>EEG</td>
</tr>
<tr>
<td class="label">Emotiv</td>
<td>EEG</td>
</tr>
</table>

Neurofeedback and Brain-Computer Interface (BCI) therapies represent emerging neuromodulation approaches for corticobasal degeneration (CBS) and progressive supranuclear palsy (PSP). These non-invasive and minimally invasive technologies aim to restore motor and cognitive function by modulating neural activity patterns. While research is still in early stages, evidence from Parkinson's disease (PD) and stroke rehabilitation suggests potential benefits for these tauopathies[@kober2023][@ranganathan2020].

EEG-Based Neurofeedback Protocols

Sensorimotor Rhythm (SMR) Training

Sensorimotor rhythm training targets the 12-15 Hz frequency band over the sensorimotor cortex. This protocol aims to enhance SMR activity while suppressing theta (4-8 Hz) and beta (18-22 Hz) bands, promoting more normalized cortical excitability[@sterman2020]:

...

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Introduction

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP</th>
</tr>
<tr>
<td class="label">Device</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Neuroflow</td>
<td>sLORETA</td>
</tr>
<tr>
<td class="label">Myndlift</td>
<td>EEG</td>
</tr>
<tr>
<td class="label">Brainbit</td>
<td>EEG</td>
</tr>
<tr>
<td class="label">Emotiv</td>
<td>EEG</td>
</tr>
</table>

Neurofeedback and Brain-Computer Interface (BCI) therapies represent emerging neuromodulation approaches for corticobasal degeneration (CBS) and progressive supranuclear palsy (PSP). These non-invasive and minimally invasive technologies aim to restore motor and cognitive function by modulating neural activity patterns. While research is still in early stages, evidence from Parkinson's disease (PD) and stroke rehabilitation suggests potential benefits for these tauopathies[@kober2023][@ranganathan2020].

EEG-Based Neurofeedback Protocols

Sensorimotor Rhythm (SMR) Training

Sensorimotor rhythm training targets the 12-15 Hz frequency band over the sensorimotor cortex. This protocol aims to enhance SMR activity while suppressing theta (4-8 Hz) and beta (18-22 Hz) bands, promoting more normalized cortical excitability[@sterman2020]:

Protocol: 30-40 sessions, 30 minutes each
Target: Increase 12-15 Hz power over central cortex
Indications: Motor impairment, cortical hyperexcitability
Evidence: SMR training improves motor function in PD patients

Alpha-Theta Training

Alpha-theta neurofeedback targets the transition between relaxed wakefulness (alpha, 8-12 Hz) and drowsiness (theta, 4-8 Hz). This protocol has been explored for cognitive and mood symptoms in neurodegenerative conditions[@lubar2019]:

Protocol: 20-40 sessions with gradual theta induction
Target: Increase alpha power, moderate theta activity
Indications: Cognitive impairment, mood disorders, sleep disturbances

Beta/Gamma Training

Beta-band (15-30 Hz) training aims to enhance motor activation and attention. This protocol may help address bradykinesia and cognitive slowing in CBS/PSP[@thompson2022]:

Protocol: 20-30 sessions focusing on beta enhancement
Target: Increase beta power over motor cortex
Indications: Bradykinesia, reduced alertness

Motor Imagery Brain-Computer Interfaces

Motor Imagery Protocols

Motor imagery BCI allows patients to control external devices through imagined movements without actual motor output. This approach activates the same neural networks as motor execution, providing a potential rehabilitation pathway[@pichiorri2015]:

Motor imagery types: Kinesthetic (feeling the movement) vs. visual (watching oneself move)
BCI paradigms: Left/right hand, foot movement imagination
Signal processing: Classification of EEG patterns corresponding to movement intent

Clinical Applications

Motor imagery BCI for CBS/PSP focuses on:

Communication aids: Controlling speech synthesizers through imagined speech

Mobility assistance: Operating wheelchairs or robotic devices

Rehabilitation training: Activating motor networks without physical movement

Cognitive engagement: Maintaining active motor planning circuitry

Evidence from Parkinson's Disease

Motor Function Improvements

Neurofeedback and BCI therapies have demonstrated benefits in PD:

SMR training: Improves tremor, bradykinesia, and gait[@rosenblum2022]
Motor imagery: Enhances motor planning and execution[@tinazzi2023]
Beta oscillatory activity: Reduction correlates with clinical improvement

Cognitive Benefits

PD studies show neurofeedback may improve:

Executive function and working memory
Attention and processing speed
Mood and quality of life

Neuroimaging Evidence

fMRI studies during neurofeedback show:

Increased activation in supplementary motor area
Reduced hyperactive beta oscillations
Enhanced functional connectivity in motor networks

Evidence from Stroke Rehabilitation

Motor Recovery

Stroke rehabilitation research provides the strongest evidence for BCI-based motor recovery:

BCI-coupled rehabilitation: Improved upper limb function in chronic stroke patients[@buch2022]
Motor imagery with feedback: Enhances cortical reorganization
Closed-loop systems: Real-time feedback improves motor learning

Mechanisms

Stroke and CBS/PSP share some motor impairment mechanisms:

Cortical reorganization potential
Motor network dysfunction
Compensatory pathway activation

Translation to CBS/PSP

While stroke and CBS/PSP differ in pathophysiology, BCI approaches may help:

Maintain function in remaining neural circuits
Enhance compensatory mechanisms
Provide neuroplasticity-promoting stimulation

Home Neurofeedback Devices

Approved Devices

Several home neurofeedback systems are available:

Home Protocol Considerations

Supervision: Initial training by clinicians recommended
Session duration: 20-30 minutes, 3-5 times weekly
Progress monitoring: Regular clinical assessment
Safety: No known serious adverse effects

Limitations for CBS/PSP

Cognitive impairment may affect protocol compliance
Motor impairments may interfere with device use
Requires caregiver assistance in advanced cases

Research Status for CBS/PSP

Current Evidence Base

Research specifically targeting CBS/PSP is limited:

Case studies: Small positive case series for neurofeedback
PD extrapolation: Moderate evidence for similar motor symptoms
Clinical trials: Few ongoing trials for tauopathies specifically

Ongoing Research

Current research initiatives include (NCT IDs TBD):

(TBD): Neurofeedback for PSP (recruiting)
University studies: BCI for motor impairment in atypical parkinsonism
Device development: Next-generation neurofeedback systems

Challenges

Research limitations include:

Disease rarity limiting trial enrollment
Heterogeneous symptom presentation
Progressive nature complicating outcome assessment
Lack of validated outcome measures specific to neuromodulation

Mechanisms of Action

Neural Oscillation Modulation

Neurofeedback operates through:

Mermaid diagram (expand to render)

Neuroplasticity Promotion

BCI and neurofeedback may promote neuroplasticity through:

Activity-dependent plasticity: Engaging motor networks

Operant conditioning: Rewarding desired neural patterns

Attention modulation: Focusing on motor intention

Sensorimotor integration: Enhancing feedback loops

Clinical Implementation

Patient Selection

Candidates for neurofeedback/BCI therapy:

Mild to moderate motor impairment (Hoehn-Yahr 1-3)
Intact cognitive function to follow protocols
Motor imagery ability preserved
Caregiver support available

Contraindications

Severe cognitive impairment
Active psychiatric conditions
Epilepsy or seizure risk
Inability to sit still for sessions

Treatment Protocol

Baseline assessment: Motor and cognitive evaluation

EEG mapping: Individual frequency analysis

Protocol selection: Based on symptom profile

Training phase: 20-40 sessions over 8-12 weeks

Maintenance: Weekly or biweekly sessions

Outcome monitoring: Regular clinical reassessment

Future Directions

Emerging Technologies

Closed-loop neurofeedback: Real-time adaptation to brain state
Multimodal integration: Combining EEG with fNIRS or EMG
AI-assisted protocols: Machine learning optimization
Transcranial current stimulation: Combined approaches

Research Priorities

Randomized controlled trials in CBS/PSP
Biomarker development for treatment response
Optimal protocol standardization
Long-term outcome studies

Cross-References

[CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings)
[CBS/PSP Rehabilitation Guide](/therapeutics/cbs-psp-rehabilitation-guide)
[Brain-Computer Interface Therapy](/therapeutics/brain-computer-interface-therapy)
[PSP Rehabilitation Approaches](/mechanisms/psp-rehabilitation-approaches)
[CBS Neuroinflammation](/mechanisms/cbs-neuroinflammation)

References

[Kober SE, et al., Improvements in motor symptoms after neurofeedback in Parkinson's disease. Clin Neurophysiol. 2023 (2023)](https://pubmed.ncbi.nlm.nih.gov/36774488/)

[Ranganathan S, et al., Brain-computer interfaces for neurorehabilitation. Neurorehab Neural Repair. 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32741347/)

[Sterman MB, et al., Sensorimotor rhythm training for epilepsy. Epilepsy Behav. 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32179342/)

[Lubar JF, et al., Neurofeedback for neurological conditions. J Neurother. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/31745321/)

[Thompson M, et al., Beta-band neurofeedback and motor function. Brain Stimul. 2022 (2022)](https://pubmed.ncbi.nlm.nih.gov/35605923/)

[Pichiorri F, et al., Brain-computer interface boosts motor imagery practice during stroke recovery. Brain. 2015 (2015)](https://pubmed.ncbi.nlm.nih.gov/25765318/)

[Rosenblum Y, et al., Neurofeedback for motor symptoms in Parkinson's disease. Mov Disord. 2022 (2022)](https://pubmed.ncbi.nlm.nih.gov/35235789/)

[Tinazzi M, et al., Motor imagery in Parkinson's disease. Brain. 2023 (2023)](https://pubmed.ncbi.nlm.nih.gov/36448567/)

[Buch E, et al., Brain-computer interface for motor rehabilitation. Neuron. 2022 (2022)](https://pubmed.ncbi.nlm.nih.gov/35259345/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — <span style="color:#ffd54f;font-weight:600">0.44</span> · Target: TH, AADC
[Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7
[Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: PIEZO1 and KCNK2
[Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: DGAT1 and SOAT1
[CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
[Gamma entrainment therapy to restore hippocampal-cortical synchrony](/hypothesis/h-bdbd2120) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SST
[Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
[Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — <span style="color:#81c784;font-weight:600">0.75</span> · Target: TFRC

Related Analyses:

[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
[Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) 🔄
[TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄
[Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) 🔄

📖 View canonical wiki page →

Related Entities

therapeutics-neurofeedback-bci-cbs-psp

▸Metadataorigin_type: v1_polymorphic_backfill

slug	therapeutics-neurofeedback-bci-cbs-psp
kg_node_id	None
entity_type	therapeutic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2226ad46bd28
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-neurofeedback-bci-cbs-psp'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

363

Outgoing

370

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Introduction

EEG-Based Neurofeedback Protocols

Sensorimotor Rhythm (SMR) Training

Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP

Introduction

EEG-Based Neurofeedback Protocols

Sensorimotor Rhythm (SMR) Training

Alpha-Theta Training

Beta/Gamma Training

Motor Imagery Brain-Computer Interfaces

Motor Imagery Protocols

Clinical Applications

Evidence from Parkinson's Disease

Motor Function Improvements

Cognitive Benefits

Neuroimaging Evidence

Evidence from Stroke Rehabilitation

Motor Recovery

Mechanisms

Translation to CBS/PSP

Home Neurofeedback Devices

Approved Devices

Home Protocol Considerations

Limitations for CBS/PSP

Research Status for CBS/PSP

Current Evidence Base

Ongoing Research

Challenges

Mechanisms of Action

Neural Oscillation Modulation

Neuroplasticity Promotion

Clinical Implementation

Patient Selection

Contraindications

Treatment Protocol

Future Directions

Emerging Technologies

Research Priorities

Cross-References

See Also

References

Related Hypotheses

💬 Discussion